EPOPROSTENOL
Generic: EPOPROSTENOL
Sun Pharmaceutical IndustriesManufacturer
INTRAVENOUSRoute
EPOPROSTENOL SODIUMActive Substance
2021-01-15Original Approval
EPOPROSTENOL is FDA application ANDA210473, sponsored by SUN PHARM. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DRUG INEFFECTIVE
263 reports
2
DYSPNOEA
201 reports
3
HEADACHE
184 reports
4
OFF LABEL USE
171 reports
5
DIARRHOEA
140 reports
6
CONDITION AGGRAVATED
137 reports
7
NAUSEA
133 reports
8
RIGHT VENTRICULAR FAILURE
117 reports
9
PAIN IN JAW
101 reports
10
PULMONARY ARTERIAL HYPERTENSION
100 reports